Stephen R Fussell Insider Trading $ABT ABBOTT LABORATORIES
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen R Fussell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen R Fussell. Stephen R Fussell is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT).
Stephen R Fussell in ABBOTT LABORATORIES
Trading Symbol: ABTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen R Fussell: Executive Vice President, Senior Vice President
Holdings: 225,935 shares
Current Value: $9,690,352
Latest Transaction: Apr 24 2019
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stephen R Fussell in ABBOTT LABORATORIES
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 34.94 | 149,600 | 5,227,024 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 32,143 | 2,017,938 | 343,709 | 375.9 K to 343.7 K (-8.55 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 800 | 50,222 | 375,852 | 376.7 K to 375.9 K (-0.21 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 1,328 | 83,365 | 376,652 | 378 K to 376.7 K (-0.35 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 6,986 | 438,511 | 377,980 | 385 K to 378 K (-1.81 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 800 | 50,214 | 384,966 | 385.8 K to 385 K (-0.21 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 4,886 | 306,670 | 385,766 | 390.7 K to 385.8 K (-1.25 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 3,703 | 232,400 | 390,652 | 394.4 K to 390.7 K (-0.94 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 4,724 | 296,455 | 394,355 | 399.1 K to 394.4 K (-1.18 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 53,383 | 3,349,783 | 399,079 | 452.5 K to 399.1 K (-11.80 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 2,615 | 164,085 | 452,462 | 455.1 K to 452.5 K (-0.57 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 83,546 | 5,242,094 | 455,077 | 538.6 K to 455.1 K (-15.51 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 8,400 | 527,016 | 538,623 | 547 K to 538.6 K (-1.54 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 4,017 | 252,006 | 547,023 | 551 K to 547 K (-0.73 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 5,903 | 370,295 | 551,040 | 556.9 K to 551 K (-1.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 3,010 | 188,802 | 556,943 | 560 K to 556.9 K (-0.54 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.72 | 9 | 564 | 559,953 | 560 K to 560 K (0.00 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.71 | 100 | 6,271 | 559,962 | 560.1 K to 560 K (-0.02 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.71 | 500 | 31,353 | 560,062 | 560.6 K to 560.1 K (-0.09 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.70 | 356 | 22,321 | 560,562 | 560.9 K to 560.6 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.70 | 300 | 18,809 | 560,918 | 561.2 K to 560.9 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.69 | 300 | 18,806 | 561,218 | 561.5 K to 561.2 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.68 | 1,000 | 62,680 | 561,518 | 562.5 K to 561.5 K (-0.18 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.68 | 100 | 6,268 | 562,518 | 562.6 K to 562.5 K (-0.02 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.67 | 300 | 18,800 | 562,618 | 562.9 K to 562.6 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.66 | 3,303 | 206,966 | 562,918 | 566.2 K to 562.9 K (-0.58 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.66 | 500 | 31,328 | 566,221 | 566.7 K to 566.2 K (-0.09 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.65 | 4,400 | 275,660 | 566,721 | 571.1 K to 566.7 K (-0.77 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 38.40 | 104,642 | 4,018,253 | 571,121 | 466.5 K to 571.1 K (+22.43 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 39.12 | 134,741 | 5,271,068 | 466,479 | 331.7 K to 466.5 K (+40.62 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 34.94 | 149,600 | 5,227,024 | 331,738 | 182.1 K to 331.7 K (+82.14 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 27.03 | 44,000 | 1,189,478 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 22.39 | 45,800 | 1,025,549 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.19 | 28,700 | 751,593 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.02 | 38,700 | 1,006,781 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.70 | 39,350 | 1,050,539 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 49.50 | 196,550 | 9,729,225 | 182,138 | 378.7 K to 182.1 K (-51.90 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 27.03 | 44,000 | 1,189,478 | 378,688 | 334.7 K to 378.7 K (+13.15 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 22.39 | 45,800 | 1,025,549 | 334,688 | 288.9 K to 334.7 K (+15.85 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.19 | 28,700 | 751,593 | 288,888 | 260.2 K to 288.9 K (+11.03 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.02 | 38,700 | 1,006,781 | 260,188 | 221.5 K to 260.2 K (+17.47 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.70 | 39,350 | 1,050,539 | 221,488 | 182.1 K to 221.5 K (+21.60 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 27.03 | 44,000 | 1,189,478 | 0 | |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 22.39 | 45,800 | 1,025,549 | 0 | |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.19 | 28,700 | 751,593 | 0 | |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.02 | 38,700 | 1,006,781 | 0 | |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.70 | 39,350 | 1,050,539 | 0 | |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.00 | 195,700 | 9,002,200 | 182,138 | 377.8 K to 182.1 K (-51.79 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.01 | 300 | 13,803 | 377,838 | 378.1 K to 377.8 K (-0.08 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.02 | 500 | 23,010 | 378,138 | 378.6 K to 378.1 K (-0.13 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.93 | 50 | 2,347 | 378,638 | 378.7 K to 378.6 K (-0.01 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 27.03 | 44,000 | 1,189,478 | 378,688 | 334.7 K to 378.7 K (+13.15 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 22.39 | 45,800 | 1,025,549 | 334,688 | 288.9 K to 334.7 K (+15.85 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.19 | 28,700 | 751,593 | 288,888 | 260.2 K to 288.9 K (+11.03 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.02 | 38,700 | 1,006,781 | 260,188 | 221.5 K to 260.2 K (+17.47 %) |
Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.70 | 39,350 | 1,050,539 | 221,488 | 182.1 K to 221.5 K (+21.60 %) |
Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 11,380 | 517,335 | 182,138 | 193.5 K to 182.1 K (-5.88 %) |
Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 44.40 | 182,242 | 8,091,545 | 182,242 | |
Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 26,351 | 0 | 193,518 | 167.2 K to 193.5 K (+15.76 %) |
Feb 02 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | P | 40.77 | 12,200 | 497,394 | 167,167 | 155 K to 167.2 K (+7.87 %) |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 25.25 | 41,500 | 1,047,713 | 0 | |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 45.02 | 7,000 | 315,140 | 154,967 | 162 K to 155 K (-4.32 %) |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 45.00 | 34,500 | 1,552,500 | 161,967 | 196.5 K to 162 K (-17.56 %) |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 25.25 | 41,500 | 1,047,713 | 196,467 | 155 K to 196.5 K (+26.78 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 39.26 | 1,340 | 52,610 | 154,967 | 156.3 K to 155 K (-0.86 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 39.27 | 62 | 2,434 | 156,307 | 156.4 K to 156.3 K (-0.04 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 39.52 | 10,039 | 396,741 | 156,369 | 166.4 K to 156.4 K (-6.03 %) |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 38.40 | 313,926 | 12,054,758 | 313,926 | |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 35,807 | 0 | 166,408 | 130.6 K to 166.4 K (+27.42 %) |
Aug 20 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 50.48 | 300 | 15,143 | 130,601 | 130.9 K to 130.6 K (-0.23 %) |
Aug 20 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 50.47 | 1,300 | 65,614 | 130,901 | 132.2 K to 130.9 K (-0.98 %) |
Aug 20 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 50.47 | 1,000 | 50,470 | 132,201 | 133.2 K to 132.2 K (-0.75 %) |
Aug 20 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 50.46 | 100 | 5,046 | 133,201 | 133.3 K to 133.2 K (-0.08 %) |
Aug 20 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 50.46 | 10,396 | 524,582 | 133,301 | 143.7 K to 133.3 K (-7.23 %) |
Aug 13 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 21.22 | 41,500 | 880,605 | 0 | |
Aug 13 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 50.66 | 28,404 | 1,438,947 | 143,697 | 172.1 K to 143.7 K (-16.50 %) |
Aug 13 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 21.22 | 41,500 | 880,605 | 172,101 | 130.6 K to 172.1 K (+31.78 %) |
Mar 03 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 47.61 | 11,459 | 545,563 | 130,601 | 142.1 K to 130.6 K (-8.07 %) |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 47.00 | 169,227 | 7,953,669 | 169,227 | |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 24,015 | 0 | 142,060 | 118 K to 142.1 K (+20.34 %) |
Sep 19 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 23.22 | 17,400 | 404,000 | 0 | |
Sep 19 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 22.27 | 14,500 | 322,872 | 0 | |
Sep 19 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 43.38 | 23,619 | 1,024,592 | 118,045 | 141.7 K to 118 K (-16.67 %) |
Sep 19 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 23.22 | 17,400 | 404,000 | 141,664 | 124.3 K to 141.7 K (+14.00 %) |
Sep 19 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 22.27 | 14,500 | 322,872 | 124,264 | 109.8 K to 124.3 K (+13.21 %) |
Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 39.79 | 13,414 | 533,743 | 109,764 | 123.2 K to 109.8 K (-10.89 %) |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 39.12 | 134,741 | 5,271,068 | 134,741 | |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 22,009 | 0 | 123,178 | 101.2 K to 123.2 K (+21.75 %) |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 19.72 | 1,227 | 24,192 | 0 | |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 25.17 | 7,558 | 190,266 | 0 | |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 25.52 | 2,908 | 74,226 | 0 | |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 37.64 | 642 | 24,165 | 101,169 | 101.8 K to 101.2 K (-0.63 %) |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 19.72 | 1,227 | 24,192 | 101,811 | 100.6 K to 101.8 K (+1.22 %) |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 37.59 | 10,466 | 393,417 | 100,584 | 111.1 K to 100.6 K (-9.42 %) |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 25.17 | 7,558 | 190,266 | 111,050 | 103.5 K to 111.1 K (+7.30 %) |
Nov 08 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 25.52 | 2,908 | 74,226 | 103,492 | 100.6 K to 103.5 K (+2.89 %) |
Mar 01 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 34.26 | 11,974 | 410,229 | 100,584 | 112.6 K to 100.6 K (-10.64 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | A | 34.94 | 149,600 | 5,227,024 | 149,600 | |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 34.80 | 666 | 23,177 | 112,558 | 113.2 K to 112.6 K (-0.59 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 34.80 | 2,400 | 83,525 | 113,224 | 115.6 K to 113.2 K (-2.08 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Payment of Exercise | F | 35.08 | 8,269 | 290,077 | 115,624 | 123.9 K to 115.6 K (-6.67 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Grant | A | 0.00 | 28,800 | 0 | 123,893 | 95.1 K to 123.9 K (+30.29 %) |
Feb 04 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 31.90 | 9,690 | 309,123 | 0 | |
Feb 04 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 33.89 | 9,690 | 328,394 | 95,093 | 104.8 K to 95.1 K (-9.25 %) |
Feb 04 2013 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 31.90 | 9,690 | 309,123 | 104,783 | 95.1 K to 104.8 K (+10.19 %) |
Oct 26 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 60.39 | 5,948 | 359,200 | 0 | |
Oct 26 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 66.00 | 2,000 | 132,000 | 95,093 | 97.1 K to 95.1 K (-2.06 %) |
Oct 26 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 66.00 | 5,948 | 392,568 | 97,093 | 103 K to 97.1 K (-5.77 %) |
Oct 26 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 60.39 | 5,948 | 359,200 | 103,041 | 97.1 K to 103 K (+6.13 %) |
Aug 01 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | A | 66.39 | 9,690 | 643,319 | 9,690 | |
Aug 01 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 53.00 | 10,988 | 582,364 | 0 | |
Aug 01 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Payment of Exercise | F | 66.39 | 9,690 | 643,319 | 97,093 | 106.8 K to 97.1 K (-9.07 %) |
Aug 01 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 53.00 | 10,988 | 582,364 | 106,783 | 95.8 K to 106.8 K (+11.47 %) |
Jul 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 50.95 | 2,275 | 115,911 | 0 | |
Jul 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 64.42 | 2,275 | 146,558 | 95,795 | 98.1 K to 95.8 K (-2.32 %) |
Jul 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 50.95 | 2,275 | 115,911 | 98,070 | 95.8 K to 98.1 K (+2.37 %) |
Jun 04 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 61.21 | 4,100 | 250,961 | 95,795 | 99.9 K to 95.8 K (-4.10 %) |
Jun 04 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 61.21 | 1,900 | 116,301 | 99,895 | 101.8 K to 99.9 K (-1.87 %) |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | A | 60.39 | 5,948 | 359,200 | 5,948 | |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 47.82 | 5,818 | 278,217 | 0 | |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 33.23 | 1,525 | 50,678 | 0 | |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Payment of Exercise | F | 60.39 | 5,948 | 359,200 | 101,795 | 107.7 K to 101.8 K (-5.52 %) |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 47.82 | 5,818 | 278,217 | 107,743 | 101.9 K to 107.7 K (+5.71 %) |
Mar 23 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 33.23 | 1,525 | 50,678 | 101,925 | 100.4 K to 101.9 K (+1.52 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 56.71 | 200 | 11,341 | 100,400 | 100.6 K to 100.4 K (-0.20 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 56.70 | 200 | 11,340 | 100,600 | 100.8 K to 100.6 K (-0.20 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 56.70 | 467 | 26,479 | 100,800 | 101.3 K to 100.8 K (-0.46 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 56.70 | 40 | 2,268 | 101,267 | 101.3 K to 101.3 K (-0.04 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Payment of Exercise | F | 57.04 | 10,259 | 585,173 | 101,307 | 111.6 K to 101.3 K (-9.20 %) |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | A | 56.26 | 44,000 | 2,475,440 | 44,000 | |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Grant | A | 0.00 | 24,400 | 0 | 111,566 | 87.2 K to 111.6 K (+27.99 %) |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 53.63 | 21,281 | 1,141,194 | 0 | |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 54.24 | 800 | 43,393 | 87,166 | 88 K to 87.2 K (-0.91 %) |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 54.24 | 800 | 43,392 | 87,966 | 88.8 K to 88 K (-0.90 %) |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 54.24 | 300 | 16,272 | 88,766 | 89.1 K to 88.8 K (-0.34 %) |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 54.24 | 19,381 | 1,051,225 | 89,066 | 108.4 K to 89.1 K (-17.87 %) |
Feb 03 2012 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 53.63 | 21,281 | 1,141,194 | 108,447 | 87.2 K to 108.4 K (+24.41 %) |
Sep 14 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Option Exercise | M | 44.16 | 450 | 19,872 | 0 | |
Sep 14 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 49.87 | 450 | 22,442 | 126 | 576 to 126 (-78.12 %) |
Sep 14 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Buy | M | 44.16 | 450 | 19,872 | 576 | 126 to 576 (+357.14 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.92 | 200 | 10,584 | 87,166 | 87.4 K to 87.2 K (-0.23 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.92 | 2,023 | 107,059 | 87,366 | 89.4 K to 87.4 K (-2.26 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.92 | 900 | 47,630 | 89,389 | 90.3 K to 89.4 K (-1.00 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.93 | 100 | 5,293 | 90,289 | 90.4 K to 90.3 K (-0.11 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.93 | 509 | 26,942 | 90,389 | 90.9 K to 90.4 K (-0.56 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.93 | 200 | 10,587 | 90,898 | 91.1 K to 90.9 K (-0.22 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.92 | 200 | 10,585 | 91,098 | 91.3 K to 91.1 K (-0.22 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.95 | 1,725 | 91,340 | 91,298 | 93 K to 91.3 K (-1.85 %) |
Jul 27 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 52.95 | 143 | 7,572 | 93,023 | 93.2 K to 93 K (-0.15 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Senior Vice Preside ... | Sell | S | 47.93 | 1,564 | 74,967 | 136,174 | 137.7 K to 136.2 K (-1.14 %) |